Recce Pharmaceuticals Ltd
ASX:RCE
Recce Pharmaceuticals Ltd
Cash from Investing Activities
Recce Pharmaceuticals Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Cash from Investing Activities
-AU$530.5k
|
CAGR 3-Years
-122%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Investing Activities
AU$473.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Investing Activities
-AU$211.5m
|
CAGR 3-Years
-3 179%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-171%
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Cash from Investing Activities
-AU$16.7m
|
CAGR 3-Years
-902%
|
CAGR 5-Years
-332%
|
CAGR 10-Years
N/A
|
|
Probiotec Ltd
ASX:PBP
|
Cash from Investing Activities
-AU$14.4m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Investing Activities
AU$3.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Recce Pharmaceuticals Ltd's Cash from Investing Activities?
Cash from Investing Activities
-530.5k
AUD
Based on the financial report for Dec 31, 2023, Recce Pharmaceuticals Ltd's Cash from Investing Activities amounts to -530.5k AUD.
What is Recce Pharmaceuticals Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-42%
The average annual Cash from Investing Activities growth rates for Recce Pharmaceuticals Ltd have been -122% over the past three years , -42% over the past five years .